[Cases of herpetic and cytomegalovirus lesions of the eye].
Kaliberdina
A F
AF
Teplinskaia
D E
DE
Rozanova
E B
EB
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy; D015817:Eye Infections / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D007978:Levamisole / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D011994:Recombinant Proteins; D013997:Time Factors; D014605:Uveitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014792:Visual Acuity
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D007978:Levamisole; D000212:Acyclovir